Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Genital Neoplasms, Female × rucaparib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Ovarian Neoplasms 2 Neoplasms 2 Breast Neoplasms 2 Triple Negative Breast Neoplasms 1 Prostatic Neoplasms 1 Metastatic Castration Resistant Prostate Cancer 1 Genital Neoplasms, Female 1 Fallopian Tube Neoplasms 1 Advanced Solid Tumors 1 Advanced Solid Tumor 1

Interventions

temsirolimus 1 rucaparib 1 niraparib 1 atezolizumab 1 Topotecan 1 Fulvestrant 1 Cell Count 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03101280 2020-10-22

A Combination Study of Rucaparib and Atezolizumab in Participants With Advanced Gynecologic Cancers and Triple-Negative Breast Cancer

Hoffmann-La Roche

Phase 1 Completed

Genital Neoplasms, Female

Data powered by HemOnc (CC BY 4.0) Colophon ⚡